[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BluntForceOptions [@BluntForceOpt](/creator/twitter/BluntForceOpt) on x XXX followers Created: 2025-06-30 15:26:53 UTC ICYMI: $KYTX has named Marc Grasso as its new Chief Financial Officer. Grasso previously served as CFO at $ALEC and brings experience from multiple clinical-stage biotech co's. Former CFO Ryan Jones will stay on in a strategic advisory role to help with the transition. CFO transitions are always notable, IMO, especially at the clinical stage. Worth keeping an eye on as Kyverna navigates its next phase of development  XXX engagements  **Related Topics** [cos](/topic/cos) [$alec](/topic/$alec) [$kytx](/topic/$kytx) [Post Link](https://x.com/BluntForceOpt/status/1939707217583960503)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BluntForceOptions @BluntForceOpt on x XXX followers
Created: 2025-06-30 15:26:53 UTC
ICYMI: $KYTX has named Marc Grasso as its new Chief Financial Officer. Grasso previously served as CFO at $ALEC and brings experience from multiple clinical-stage biotech co's. Former CFO Ryan Jones will stay on in a strategic advisory role to help with the transition.
CFO transitions are always notable, IMO, especially at the clinical stage. Worth keeping an eye on as Kyverna navigates its next phase of development
XXX engagements
/post/tweet::1939707217583960503